Detalles de la búsqueda
1.
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
N Engl J Med
; 381(19): 1820-1830, 2019 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562798
2.
Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
Catheter Cardiovasc Interv
; 97(5): 766-773, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32181569
3.
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Eur Heart J
; 40(24): 1930-1941, 2019 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919909
4.
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
Circulation
; 137(5): 464-479, 2018 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089314
5.
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
N Engl J Med
; 375(23): 2223-2235, 2016 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27797291
6.
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
Eur Heart J
; 36(20): 1231-41, 2015 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25583761
7.
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.
Am Heart J
; 230: 93-97, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33011148
8.
Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).
Circulation
; 126(10): 1225-36, 2012 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22824435
9.
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
N Engl J Med
; 362(18): 1663-74, 2010 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20445180
10.
Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial.
Am Heart J
; 166(6): 1035-42, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24268218
11.
An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization.
Catheter Cardiovasc Interv
; 82(5): 709-14, 2013 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23765902
12.
Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V® everolimus-eluting stents: one-year results from the XIENCE V USA study.
Catheter Cardiovasc Interv
; 82(4): E385-94, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23172848
13.
Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries.
EuroIntervention
; 17(5): e380-e387, 2021 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32863243
14.
Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial.
J Invasive Cardiol
; 33(8): E619-E627, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34170842
15.
Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial.
EuroIntervention
; 16(12): e982-e988, 2020 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31793882
16.
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.
J Am Coll Cardiol
; 76(14): 1609-1621, 2020 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33004126
17.
Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.
JACC Cardiovasc Interv
; 13(3): 375-387, 2020 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31954680
18.
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
Am Heart J
; 158(4): 520-526.e2, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19781409
19.
Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
J Am Coll Cardiol
; 73(13): 1616-1628, 2019 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30947913
20.
Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel meeting on the ACCULINK and ACCUNET Carotid Artery Stent System.
Circulation
; 125(18): 2256-64, 2012 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22566349